BridgeMD
New treatment option for Carpal Tunnel Syndrome (CTS)
Official title Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse Test, in Carpal Tunnel Syndrome.
ClinicalTrials.gov ID: NCT07248124
What this study is testing
- What it's testing
- The Scratch Collapse Test (SCT) is a neurocutaneous reflex used to detect peripheral nerve compression in nerve tunnel syndromes. It first involves applying a sensory stimulus to the skin over the suspected nerve compression point, then bilaterally testing the strength of a specific muscle in the patient.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient over 18 years old
- Patient with clinical unilateral carpal tunnel syndrome diagnosed by history, clinical examination and electromyography,
- Patient who has been informed and has given their free, informed, and written consent,
- Patient affiliated with or beneficiary of a social security scheme.
You likely can't join if
- Other associated canal syndrome on either side (ulnar, defilement, lacertus),
- Rotator cuff pathology, insufficiency or rupture of the infraspinatus,
- Associated cervical pathology,
- Neuropathy, central or peripheral neurological disease,
- Diabetic patient,
- Patient with cognitive impairments that prevent the understanding of the study information,
See the full eligibility criteria
- Patient over 18 years old
- Patient with clinical unilateral carpal tunnel syndrome diagnosed by history, clinical examination and electromyography,
- Patient who has been informed and has given their free, informed, and written consent,
- Patient affiliated with or beneficiary of a social security scheme.
- Other associated canal syndrome on either side (ulnar, defilement, lacertus),
- Rotator cuff pathology, insufficiency or rupture of the infraspinatus,
- Associated cervical pathology,
- Neuropathy, central or peripheral neurological disease,
- Diabetic patient,
- Patient with cognitive impairments that prevent the understanding of the study information,
- Refusal to participate in the study,
- Pregnant, parturient, or breastfeeding woman,
- Patient under legal protection,
- Patient not receiving health protection,
- Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative decision
The study team makes the final eligibility decision.
Where it's taking place
- Tarbes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tarbes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.